Castle Biosciences Inc.

21.34
-0.34 (-1.57%)
At close: Mar 03, 2025, 3:59 PM
21.27
-0.33%
After-hours: Mar 03, 2025, 04:54 PM EST

Castle Biosciences Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio 40.57 -10.06 -9.14 -34.44 -123.6 55.91 -35.8 -16.93
PEG Ratio -0.31 0.59 -0.08 -0.27 0.49 -0.35 0.68 n/a
PS Ratio 2.23 2.63 4.48 11.45 20.29 5.69 10.00 15.22
PB Ratio 1.62 1.48 1.54 2.62 3.06 3.47 -22.64 -14.67
P/FCF Ratio 20.26 -30.05 -12.97 -47.97 248.55 48.54 -18.13 -16.45
P/OCF Ratio 11.41 -102.81 -14.72 -56.77 128.85 42.06 -18.54 -17.12
OCF/S Ratio 0.20 -0.03 -0.3 -0.2 0.16 0.14 -0.54 -0.89
Debt / Equity Ratio 0.06 0.04 0.03 0.02 n/a 0.30 -2.43 -1.3
Quick Ratio 7.13 6.04 7.98 14.13 20.47 7.55 2.56 1.22
Current Ratio 7.29 6.20 8.09 14.21 20.58 7.63 2.69 1.28
Asset Turnover 0.63 0.48 0.31 0.20 0.14 0.43 1.02 1.40
Interest Coverage 15.03 -6.18K -5.36K -40.08K -2.48 1.03 -1.69 -6.61
Return on Equity (ROE) 0.04 -0.15 -0.17 -0.08 -0.02 0.06 0.63 0.87
Return on Assets (ROA) 0.03 -0.13 -0.15 -0.07 -0.02 0.04 -0.28 -1.26
Return on Capital (ROIC) 0.02 -0.17 -0.22 -0.09 -0.02 0.05 -0.24 -2.37
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 79.53% 76.64% 83.18% 84.54% 85.91% 76.75% 64.21%
Net Profit Margin 5.49% -26.15% -48.99% -33.26% -16.42% 10.17% -27.94% -89.93%
Pretax Profit Margin 6.49% -26.1% -50.28% -42.53% -16.28% 10.31% -27.91% -89.86%
Operating Profit Margin 2.61% -30.93% -66.51% -42.6% -10.44% 9.08% -16.83% -79.25%
FCF Margin 11.00% -8.76% -34.51% -23.88% 8.16% 11.72% -55.17% -92.54%
EBITDA Margin 11.48% -20.49% -42.57% -38.91% -11.32% 14.82% -16.51% -75.61%